kabutan

SymBio Pharma, The Current Fiscal Year's Net Income to Widen

Thu Feb 6, 2025 3:35 pm JST Earnings

4582 SymBio Pharmaceuticals Limited 【J-GAAP】

Earnings Report

SymBio Pharmaceuticals Limited <4582> [TSE Growth] announced its financial results after the market closed on February 6th (15:35). The consolidated net loss for the fiscal year ending December 2024 expanded to a loss of 3.83 billion yen (compared to a loss of 1.96 billion yen in the previous period). In the fiscal year ending December 2025, the loss is expected to be loss of 4.46 billion yen. This will mark the third consecutive term of losses.

In the most recent three-month period, from October to December (4Q), the consolidated net loss improved to a deficit of 0.98 billion yen (compared to a loss of 1.17 billion yen in the same period last year). However, the operating profit/loss margin drastically worsened from -45.2% in the same period last year to -195.8%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 10,008 1,963 1,999 1,179 30.2 0 Feb 9, 2023 J-GAAP
Dec, 2023 5,589 -811 -736 -1,962 -49.2 0 Feb 8, 2024 J-GAAP
Dec, 2024 2,452 -3,876 -3,689 -3,833 -85.0 0 Feb 6, 2025 J-GAAP
YoY -56.1% -377.9% -401.2% -95.4% -72.8%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 2,623 -3,702 -3,524 -3,628 -79.2 0 May 7, 2024 J-GAAP
Dec, 2024 Results 2,452 -3,876 -3,689 -3,833 -85.0 0 Feb 6, 2025 J-GAAP
Revision Rate -6.5% -4.7% -4.7% -5.7% -7.4%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 1,284 -1,719 -1,481 -1,541 -34.8 0 Aug 1, 2024 J-GAAP
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 6, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 5,589 -811 -736 -1,962 -49.2 0 Feb 8, 2024 J-GAAP
Dec, 2024 2,452 -3,876 -3,689 -3,833 -85.0 0 Feb 6, 2025 J-GAAP
Dec, 2025 Guidance 1,858 -4,263 -4,347 -4,468 -81.9 0 Feb 6, 2025 J-GAAP
YoY -24.2% -10.0% -17.8% -16.6% +3.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 1,168 -528 -580 -1,174 -29.4 -45.2 Feb 8, 2024 J-GAAP
Jan - Mar, 2024 597 -806 -727 -777 -18.0 -135.0 May 7, 2024 J-GAAP
Apr - Jun, 2024 687 -913 -754 -764 -17.2 -132.9 Aug 1, 2024 J-GAAP
Jul - Sep, 2024 614 -1,072 -1,278 -1,304 -29.1 -174.6 Oct 31, 2024 J-GAAP
Oct - Dec, 2024 554 -1,085 -930 -988 -21.9 -195.8 Feb 6, 2025 J-GAAP
YoY -52.6% -105.5% -60.3% +15.8% +25.6%

Related Articles